Daniel Moritz Felsenreich1, Ronald Kefurt1, Martin Schermann2, Philipp Beckerhinn3, Ivan Kristo1, Michael Krebs4, Gerhard Prager5, Felix B Langer1. 1. Division of General Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria. 2. Department for Surgery, Hospital Rudolfsstiftung, Vienna, Austria. 3. Department for Surgery, Hospital Hollabrunn, Hollabrunn, Austria. 4. Division of Endocrinology, Department of Internal Medicine, Medical University of Vienna, Vienna, Austria. 5. Division of General Surgery, Department of Surgery, Medical University of Vienna, Vienna, Austria. gerhard.prager@meduniwien.ac.at.
Abstract
BACKGROUND: Laparoscopic sleeve gastrectomy (SG) has become the most frequently performed bariatric procedure worldwide. De novo reflux might impact patients' quality of life, requiring lifelong proton pump inhibitor medication. It also increases the risk of esophagitis and formation of Barrett's metaplasia. Besides weight regain, gastroesophageal reflux disease (GERD) is the most common reason for conversion to Roux-en-Y gastric bypass. METHODS: We performed 24-h pH metries, manometries, gastroscopies, and questionnaires focusing on reflux (GIQLI, RSI) in SG patients with a follow-up of more than 10 years who did not suffer from symptomatic reflux or hiatal hernia preoperatively. RESULTS: From a total of 53 patients, ten patients after adjustable gastric banding were excluded. From the remaining 43, six patients (14.0%) were converted to RYGB due to intractable reflux over a period of 130 months. Ten out of the remaining non-converted patients (n = 26) also suffered from symptomatic reflux. Gastroscopies revealed de novo hiatal hernias in 45% of the patients and Barrett's metaplasia in 15%. SG patients suffering from symptomatic reflux scored significantly higher in the RSI (p = 0.04) and significantly lower in the GIQLI (p = 0.02) questionnaire. CONCLUSIONS: This study shows a high incidence of Barrett's esophagus and hiatal hernias at more than 10 years after SG. Its results therefore suggest maintaining pre-existing large hiatal hernia, GERD, and Barrett's esophagus as relative contraindications to SG. The limitations of this study-its small sample size as well as the fact that it was based on early experience with SG-make drawing any general conclusions about this procedure difficult.
BACKGROUND: Laparoscopic sleeve gastrectomy (SG) has become the most frequently performed bariatric procedure worldwide. De novo reflux might impact patients' quality of life, requiring lifelong proton pump inhibitor medication. It also increases the risk of esophagitis and formation of Barrett's metaplasia. Besides weight regain, gastroesophageal reflux disease (GERD) is the most common reason for conversion to Roux-en-Y gastric bypass. METHODS: We performed 24-h pH metries, manometries, gastroscopies, and questionnaires focusing on reflux (GIQLI, RSI) in SG patients with a follow-up of more than 10 years who did not suffer from symptomatic reflux or hiatal hernia preoperatively. RESULTS: From a total of 53 patients, ten patients after adjustable gastric banding were excluded. From the remaining 43, six patients (14.0%) were converted to RYGB due to intractable reflux over a period of 130 months. Ten out of the remaining non-converted patients (n = 26) also suffered from symptomatic reflux. Gastroscopies revealed de novo hiatal hernias in 45% of the patients and Barrett's metaplasia in 15%. SG patients suffering from symptomatic reflux scored significantly higher in the RSI (p = 0.04) and significantly lower in the GIQLI (p = 0.02) questionnaire. CONCLUSIONS: This study shows a high incidence of Barrett's esophagus and hiatal hernias at more than 10 years after SG. Its results therefore suggest maintaining pre-existing large hiatal hernia, GERD, and Barrett's esophagus as relative contraindications to SG. The limitations of this study-its small sample size as well as the fact that it was based on early experience with SG-make drawing any general conclusions about this procedure difficult.
Entities:
Keywords:
Conversion to RYGB; GERD; Long-term data; Reflux; Sleeve gastrectomy
Authors: Kamran Samakar; Travis J McKenzie; Ali Tavakkoli; Ashley H Vernon; Malcolm K Robinson; Scott A Shikora Journal: Obes Surg Date: 2016-01 Impact factor: 4.129
Authors: Jessica L Reynolds; Joerg Zehetner; Phil Wu; Shawn Shah; Nikolai Bildzukewicz; John C Lipham Journal: J Am Coll Surg Date: 2015-03-05 Impact factor: 6.113
Authors: Julian Bühler; Silvan Rast; Christoph Beglinger; Ralph Peterli; Thomas Peters; Martina Gebhart; Anne Christin Meyer-Gerspach; Bettina Karin Wölnerhanssen Journal: Obes Facts Date: 2020-12-17 Impact factor: 3.942
Authors: Mario Musella; Mervyn Deitel; K S Kular; Miguel-A Carbajo; Karl P Rheinwalt; Chetan Parmar; Arun Prasad; Enrique Luque-de-Leon; Gurvinder Jammu; Roger Luciani; David Hargroder; Cesare Pereaglie; Jean Marc Chevallier Journal: Obes Surg Date: 2019-02 Impact factor: 4.129
Authors: Mario Musella; Giovanna Berardi; Alessio Bocchetti; Roberta Green; Valeria Cantoni; Nunzio Velotti; Katia Di Lauro; Domenico Manzolillo; Antonio Vitiello; Marco Milone; Giovanni Domenico De Palma Journal: Obes Surg Date: 2019-08 Impact factor: 4.129